Advertisement

Topics

Merck's Keytruda Claims Market Leadership In First-line Lung Cancer

23:53 EDT 29 Jul 2017 | SCRIP

Merck enjoyed a good second quarter, beating sales expectations for Keytruda and other drugs, which helped offset losses related to...

      

Related Stories

 

Original Article: Merck's Keytruda Claims Market Leadership In First-line Lung Cancer

NEXT ARTICLE

More From BioPortfolio on "Merck's Keytruda Claims Market Leadership In First-line Lung Cancer"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...